메뉴 건너뛰기




Volumn 8, Issue 5, 2002, Pages 193-197

Ten-year experience with an inactivated vaccine against viral hepatitis A;Deset let zkušeností s inaktivovanou očkovací látkou proti virové hepatitidě A

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; INACTIVATED VIRUS VACCINE;

EID: 17344392229     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (16)
  • 1
    • 0012717557 scopus 로고    scopus 로고
    • Jaká rizika při cestách do zahraničí Češi podceňují. Tisková zpráva, Ewing Public Relation, Praha 1
    • Jaká rizika při cestách do zahraničí Češi podceňují. Tisková zpráva, Ewing Public Relation, Praha 1, 2002.
    • (2002)
  • 2
  • 5
    • 0035215767 scopus 로고    scopus 로고
    • Inactivated Hepatitis A vaccine-induced antibodies: Follow-up and estimates of long-term persistence
    • Van Herck K, Van Damme P. Inactivated Hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001; 63: 1-7.
    • (2001) J. Med. Virol. , vol.63 , pp. 1-7
    • Van Herck, K.1    Van Damme, P.2
  • 6
    • 0012674881 scopus 로고    scopus 로고
    • FDC Reports, June 30
    • FDC Reports, June 30 1997.
    • (1997)
  • 8
    • 0012622097 scopus 로고    scopus 로고
    • Inactivated Hepatitis A vaccine: Immunogenicity, efficacy, safety and review of official recommendations for use
    • André FE, Van Damme P, Safary A, Banatvala J. Inactivated Hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use. Exp Rev Vaccines 2002; 1: 9-23.
    • (2002) Exp. Rev. Vaccines , vol.1 , pp. 9-23
    • André, F.E.1    Van Damme, P.2    Safary, A.3    Banatvala, J.4
  • 9
    • 0037765662 scopus 로고    scopus 로고
    • Rapid seroconversation rates after first dose of an inactivated hepatitis A vaccine (HAVRIX 1440 EU): Results of a retrospective analyses
    • Florence
    • Van Damme P, Lievens M, Stoffel M, Ngueyn C. Rapid seroconversation rates after first dose of an inactivated hepatitis A vaccine (HAVRIX 1440 EU): results of a retrospective analyses. Proc 3rd Eur Conf Travel Med,2002, Florence.
    • (2002) Proc. 3rd Eur. Conf. Travel Med.
    • Van Damme, P.1    Lievens, M.2    Stoffel, M.3    Ngueyn, C.4
  • 11
    • 0033519040 scopus 로고    scopus 로고
    • Efficacy of Hepatitis A vaccine in prevention of secondary Hepatitis A infection: A randomised trial
    • Sagliocca L,Amoroso P, Stroffolini T et al. Efficacy of Hepatitis A vaccine in prevention of secondary Hepatitis A infection: a randomised trial. Lancet 1999; 353:1136-9.
    • (1999) Lancet , vol.353 , pp. 1136-1139
    • Sagliocca, L.1    Amoroso, P.2    Stroffolini, T.3
  • 12
    • 0035377715 scopus 로고    scopus 로고
    • Antibody response to Hepatitis A vaccine in heathy adults
    • Irwin DJ, Millership S. Antibody response to Hepatitis A vaccine in heathy adults. Commun Dis Public Health 2001; 4: 139-140.
    • (2001) Commun. Dis. Public Health , vol.4 , pp. 139-140
    • Irwin, D.J.1    Millership, S.2
  • 13
    • 0012621788 scopus 로고    scopus 로고
    • Immunogenicity of two doses of inactivated Hepatitis A vaccine given at an interval of more than 24 months
    • European Conference on Travel Medicine, Venice
    • Landry P, Tremblay S, Darioli R. Immunogenicity of two doses of inactivated Hepatitis A vaccine given at an interval of more than 24 months. European Conference on Travel Medicine, Venice 1998.
    • (1998)
    • Landry, P.1    Tremblay, S.2    Darioli, R.3
  • 14
    • 0034668150 scopus 로고    scopus 로고
    • Inactivated Hepatitis A vaccine booster given > 24 months after the primary dose
    • Landry P, Tremblay S, Darioli R, Genton B. Inactivated Hepatitis A vaccine booster given > 24 months after the primary dose. Vaccine 2000; 19: 399-402.
    • (2000) Vaccine , vol.19 , pp. 399-402
    • Landry, P.1    Tremblay, S.2    Darioli, R.3    Genton, B.4
  • 15
    • 0036195452 scopus 로고    scopus 로고
    • Excellent booster response 4-6 Y after a single primary dose of an inactivated Hepatitis A vaccine
    • Iwarson S, Lindh M, Winderstrom I. Excellent booster response 4-6 Y after a single primary dose of an inactivated Hepatitis A vaccine. Scan J Infect Dis 2002; 34: 110-111.
    • (2002) Scan. J. Infect. Dis. , vol.34 , pp. 110-111
    • Iwarson, S.1    Lindh, M.2    Winderstrom, I.3
  • 16
    • 0012674882 scopus 로고    scopus 로고
    • Long-term persistence of cellular immunity towards hepatitis A vaccine (HAV) following HAV vaccination
    • April 9-13, Atlanta
    • Desombere I, Van Herck K, Van Damme P, et al.: Long-term persistence of cellular immunity towards hepatitis A vaccine (HAV) following HAV vaccination. 10th Intern Symp Viral hepatitis and liver disease, April 9-13, 2000, Atlanta.
    • (2000) 10th Intern Symp Viral Hepatitis and Liver Disease
    • Desombere, I.1    Van Herck, K.2    Van Damme, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.